Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GMDA

Gamida Cell Ltd

Dec 08 • 04:00PM ET

0.3200

Dollar change -0.0060
Percentage change -1.84	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.90	Insider Own	9.60%	Shs Outstand	132.64M	Perf Week	-3.03%
Market Cap	42.44M	Forward P/E	-	EPS next Y	-0.56	Insider Trans	0.00%	Shs Float	119.91M	Perf Month	-53.76%
Income	-76.95M	PEG	-	EPS next Q	-0.15	Inst Own	31.25%	Short Float / Ratio	6.89% / 4.42	Perf Quarter	-72.41%
Sales	0.67M	P/S	63.35	EPS this Y	37.90%	Inst Trans	27.31%	Short Interest	8.26M	Perf Half Y	-85.25%
Book/sh	0.00	P/B	94.12	EPS next Y	27.27%	ROA	-66.32%	Target Price	4.00	Perf Year	-75.38%
Cash/sh	0.48	P/C	0.67	EPS next 5Y	-	ROE	-1103.79%	52W Range	0.22 - 2.51	Perf YTD	-75.19%
Dividend	-	P/FCF	-	EPS past 5Y	-9.78%	ROI	-91.50%	52W High	-87.25%	Beta	1.13
Dividend %	-	Quick Ratio	3.20	Sales past 5Y	0.00%	Gross Margin	-152.45%	52W Low	46.52%	ATR	0.05
Employees	146	Current Ratio	3.32	Sales Q/Q	-	Oper. Margin	-11438.78%	RSI (14)	29.51	Volatility	8.15% 17.29%
Optionable	Yes	Debt/Eq	224.26	EPS Q/Q	95.86%	Profit Margin	-11434.03%	Rel Volume	0.72	Prev Close	0.33
Shortable	Yes	LT Debt/Eq	220.32	Earnings	Nov 14 BMO	Payout	-	Avg Volume	1.87M	Price	0.32
Recom	1.00	SMA20	-12.24%	SMA50	-51.30%	SMA200	-74.94%	Volume	1,338,300	Change	-1.84%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-01-21	Initiated	Alliance Global Partners	Buy	$11
Jul-01-20	Initiated	Evercore ISI	Outperform
May-26-20	Initiated	Piper Sandler	Overweight	$13
Apr-27-20	Initiated	H.C. Wainwright	Buy	$15
Nov-26-18	Initiated	Needham	Buy	$23
Nov-21-18	Initiated	Oppenheimer	Outperform	$15
Nov-20-18	Initiated	RBC Capital Mkts	Outperform	$20

Nov-27-23 08:11PM	Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023 (GlobeNewswire)
Nov-20-23 08:00AM	Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire) -18.65%
Nov-15-23 09:15AM	Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript (Insider Monkey)
02:45AM	Q3 2023 Gamida Cell Ltd Earnings Call (Thomson Reuters StreetEvents)
Nov-14-23 07:30AM	Gamida Cell: Q3 Earnings Snapshot (Associated Press Finance) -37.67%
07:00AM	Loading…
07:00AM	Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update (GlobeNewswire)
Nov-04-23 08:00AM	Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Nov-01-23 08:00AM	Gamida Cell to Report Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-16-23 04:39PM	Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201 (Business Wire) +9.51%
Oct-09-23 02:00PM	Gamida Cell Issues Update on Israel Operations (Business Wire)
Oct-02-23 08:00AM	Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa (Business Wire)
Sep-28-23 08:00AM	Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting (Business Wire) +7.15%
Sep-27-23 04:30PM	First Patient Receives Gamida Cell's Omisirge (omidubicel-onlv) (Business Wire)
Aug-31-23 08:00AM	Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference (Business Wire)
Aug-15-23 02:30AM	Q2 2023 Gamida Cell Ltd Earnings Call (Thomson Reuters StreetEvents)
07:27AM	Loading…
Aug-14-23 07:27AM	Gamida Cell: Q2 Earnings Snapshot (AP Finance)
07:00AM	Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update (Business Wire)
Aug-01-23 08:00AM	Gamida Cell to Report Second Quarter 2023 Financial Results (Business Wire)
Jul-11-23 08:00AM	Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cells Omisirge® (omidubicel-onlv) (Business Wire)
Jul-10-23 02:00PM	STAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE OFFICER (PR Newswire)
Jun-20-23 09:55AM	Here's Why Gamida Cell (GMDA) Looks Ripe for Bottom Fishing (Zacks)
Jun-14-23 04:30PM	Gamida Cell To Host Investor Day (Business Wire)
Jun-09-23 09:55AM	Gamida Cell (GMDA)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
May-31-23 04:30PM	Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference (Business Wire)
07:00AM	Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting (Business Wire)
May-22-23 08:00AM	Gamida Cell Appoints Terry Coelho as CFO (Business Wire)
May-17-23 07:27AM	Breakeven On The Horizon For Gamida Cell Ltd. (NASDAQ:GMDA) (Simply Wall St.) +9.36%
May-15-23 04:18PM	Gamida Cell: Q1 Earnings Snapshot (AP Finance) +6.81%
04:05PM	Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update (Business Wire)
May-11-23 05:20PM	Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast (Business Wire) +19.25%
07:24AM	Loading…
Apr-20-23 07:24AM	Insiders who bought into Gamida Cell Ltd. (NASDAQ:GMDA) earlier this year might wish they'd invested more as stock gained 113% (Simply Wall St.)
Apr-19-23 08:15AM	Gamida Cell Announces Pricing of $23 Million Public Offering of Securities (Business Wire) -5.33%
Apr-18-23 07:16PM	Gamida Cell Announces Launch of Public Offering of Securities (Business Wire) +50.89%
12:35PM	Gamida Cell (GMDA) Surges on FDA Approval for Omisirge (Zacks)
Apr-17-23 04:16PM	Gamida Cells Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval (Business Wire) +38.79%
Mar-29-23 07:28AM	Gamida Cell Ltd. (NASDAQ:GMDA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-28-23 02:12PM	Israeli-Boston cell therapy firm lays off nearly one-fifth of workforce (American City Business Journals) +12.15%
Mar-27-23 07:00AM	Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update (Business Wire) -49.63%
Mar-20-23 04:30PM	Gamida Cell Announces Changes to Board of Directors (Business Wire) -14.29%
08:00AM	Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast (Business Wire)
Mar-12-23 10:10AM	Gamida Cell Ltd.'s (NASDAQ:GMDA) largest shareholders are retail investors with 44% ownership, institutions own 29% (Simply Wall St.)
Mar-07-23 08:00AM	Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference (Business Wire)
Feb-18-23 12:30PM	Data Presented on Gamida Cells Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR (Business Wire)
Jan-16-23 12:00PM	Gamida Cell (GMDA) Upgraded to Buy: Here's Why (Zacks)
Dec-12-22 07:00AM	Gamida Cell Announces Closing of $25 Million Financing With Highbridge (Business Wire)
Nov-23-22 08:00AM	Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences (Business Wire)
Nov-21-22 04:52PM	Gamida Cell Provides Regulatory Update on Omidubicel (Business Wire)
Nov-14-22 07:00AM	Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update (Business Wire) -6.19%
Nov-10-22 08:00AM	Gamida Cell to Present Corporate Highlights at the Jefferies London Healthcare Conference (Business Wire) +6.90%
Nov-07-22 08:00AM	GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising Antitumor Activity Against HER2+ Cancers (Business Wire)
08:00AM	Gamida Cell Announces the Date of Its Third Quarter 2022 Financial Results and Webcast (Business Wire)
Nov-03-22 09:07AM	Gamida Cell Announces Omidubicel Data To Be Presented as an Oral Presentation at 64th ASH Annual Meeting (Business Wire)
Oct-10-22 07:00AM	Gamida Cell to Present Corporate Highlights at 2022 Cell & Gene Meeting on the Mesa (Business Wire)
Sep-29-22 07:00AM	Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers at the Society of Hematologic Oncology Meeting (Business Wire) +6.17%
Sep-28-22 12:08AM	Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares (Business Wire) -17.35%
12:08AM	Gamida Cell Announces Entry into Commitment Letter with Highbridge for $25 Million Financing (Business Wire)
Sep-27-22 04:06PM	Gamida Cell Announces Launch of Public Offering of Ordinary Shares (Business Wire)
Sep-22-22 05:27AM	The Petri Dish: Embattled Sesen Bio shuts down via merger (American City Business Journals)
Sep-19-22 07:00AM	Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies (Business Wire) -8.26%
Sep-12-22 08:00AM	Gamida Cell Presents Data Demonstrating the Impact of Transplantation with Omidubicel for Patients with Hematologic Malignancies at 2022 Cord Blood Connect Meeting (Business Wire)
Aug-15-22 03:00PM	Gamida Cell Ltd. (GMDA) Q2 2022 Earnings Call Transcript (Motley Fool) +7.31%
07:00AM	Gamida Cell Reports Second Quarter 2022 Financial Results and Provides Company Update (Business Wire)
Aug-10-22 07:00AM	Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201 (Business Wire) +7.32%
Aug-09-22 10:39AM	These 2 Penny Stocks Are Poised for a Big Rally, Says Oppenheimer (TipRanks) +13.36%
Aug-08-22 08:00AM	Gamida Cell Announces the Date of Its Second Quarter 2022 Financial Results and Webcast (Business Wire)
Aug-04-22 07:29AM	How Many Gamida Cell Ltd. (NASDAQ:GMDA) Shares Do Institutions Own? (Simply Wall St.)
Aug-01-22 07:00AM	Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review (Business Wire)
Jun-13-22 07:00AM	Gamida Cell to Present Corporate Highlights at the JMP Securities Life Sciences Conference (Business Wire)
Jun-10-22 07:00AM	Gamida Cell Appoints Ivan M. Borrello, M.D., Expert in Immuno-Oncology, Cell Therapies, and Bone Marrow Transplant to Board of Directors (Business Wire) -6.28%
Jun-02-22 07:00AM	Gamida Cell Completes Rolling Biologics License Application Submission to the FDA for Omidubicel (Business Wire)
Jun-01-22 04:30PM	Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference (Business Wire)
07:00AM	Gamida Cell Announces Opening to Enrollment of Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201 (Business Wire)
May-17-22 04:30PM	Gamida Cell to Present Corporate Highlights at the H.C. Wainwright Global Life Sciences Conference (Business Wire)
May-10-22 07:00AM	Gamida Cell Reports First Quarter 2022 Financial Results and Provides Company Update (Business Wire)
May-05-22 03:36PM	Gamida Cell Ltd. (NASDAQ:GMDA): When Will It Breakeven? (Simply Wall St.)
07:00AM	Gamida Cell Presents New Data from NAM-Enabled Genetically Modified Natural Killer (NK) Pipeline at International Society for Cell & Gene Therapy 2022 (Business Wire)
May-03-22 08:00AM	Gamida Cell Announces the Date of Its First Quarter 2022 Financial Results and Webcast (Business Wire)
Apr-27-22 12:31PM	Gamida Cell Posts Updated Omidubicel Data In Blood Cancer Patients (Benzinga) -7.06%
07:00AM	Gamida Cell Presents Updated One-Year Post-Transplant Follow Up Data from Phase 3 Study of Omidubicel at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings (Business Wire)
Apr-26-22 09:20AM	Gamida Cell Shares Jump On FDA Nod To Cell Therapy Trial In Blood Cancer Settings (Benzinga)
07:00AM	Gamida Cell Announces FDA Clearance of IND and Removal of Clinical Hold for NK Cell Therapy Candidate GDA-201 (Business Wire)
Apr-25-22 08:00PM	Gamida Cell Presents Updated Omidubicel Data During Best Abstract Award Session at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings (Business Wire)
04:05PM	Permian Highway Pipeline Announces Binding Open Season for Expansion Project (Business Wire)
07:00AM	Gamida Cell Announces Results of New Health Economic and Outcome Study Reporting Improved Health Equity and Health Outcomes With Omidubicel at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings (Business Wire)
Apr-21-22 08:05AM	Kinder Morgan Joins Cheniere-Led Project Focused on Greenhouse Gas Emissions (Business Wire) -6.98%
Apr-20-22 04:05PM	Kinder Morgan Increases Dividend to $0.2775 Per Share Per Quarter and Announces Results for First Quarter of 2022 (Business Wire)
Apr-07-22 08:00AM	Gamida Cell to Present Corporate Highlights and Participate in Panel Discussion at the Needham Healthcare Conference (Business Wire)
Mar-30-22 07:43AM	Pfizer (PFE) 2nd Ulcerative Colitis Study on Etrasimod Succeeds (Zacks)
Mar-29-22 10:12AM	10 Best Biotech Stocks Under $5 (Insider Monkey)
09:40AM	Has Champions Oncology, Inc. (CSBR) Outpaced Other Medical Stocks This Year? (Zacks)
Mar-28-22 11:07AM	Acadia Healthcare (ACHC) Up 10% in 3 Months: More Room to Run? (Zacks)
Mar-25-22 02:29PM	Mei Pharma (MEIP) to Delay Filing With FDA for Lymphoma Drug (Zacks)
Mar-24-22 01:57PM	Creative Medical (CELZ) Up 82% on Stem Cell Treatment Data (Zacks)
Mar-23-22 08:28AM	Vertex (VRTX) to Begin Pivotal Study on Kidney Candidate (Zacks)
Mar-21-22 01:04PM	UnitedHealth Group (UNH) Gains 38% in a Year: More Room to Run? (Zacks) -5.75%
Mar-15-22 12:01PM	Gamida Cell Ltd. (GMDA) Q4 2021 Earnings Call Transcript (Motley Fool)
11:13AM	AstraZeneca's (AZN) Fasenra sBLA for Nasal Polyps Gets CRL (Zacks)
10:52AM	AstraZeneca (AZN) Stock Up 27% in a Year: What Lies Ahead? (Zacks)
07:00AM	Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update (Business Wire)
Mar-11-22 11:27AM	Allogene's (ALLO) CAR T Therapy Gets Fast Track Designation (Zacks)

Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and unmodified nicotinamide-enabled natural killer cells targeted at solid tumor and hematological malignancies. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Boston, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GMDA

Gamida Cell Ltd

Upgrade your FINVIZ experience